News
Progenra Inc. reports that it has discovered a new class of small-molecule PINK1 activators that restore function in mutant forms of the PINK1 kinase, a key mitochondrial regulator whose dysfunction ...
Four compounds in ear canal secretions differ between those with and without Parkinson’s disease, suggesting they may be accurate biomarkers for the disease.
Researchers reported that the AI model could accurately distinguish between individuals with and without Parkinson's based on the analysis of their smiles.
Over the past two decades, our understanding of Parkinson's disease (PD) has been gleaned from the discoveries made in familial and/or sporadic forms of PD in the Caucasian population. The ...
New research suggests ear wax odor could serve as an early warning sign for Parkinson's disease, with an AI system showing 94% accuracy in detection through organic compounds.
Read this clinical update to learn how patient-reported outcomes can contribute to the research of Parkinsons.
26d
News-Medical.Net on MSNT cells play key role in early stages of Parkinson’s diseaseYour T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues. For people with autoimmune disease, T cell reactivity is a big ...
Researchers have uncovered another piece of the Parkinson’s disease puzzle, identifying that particular immune cells are active long before the hallmark motor symptoms become apparent. It paves ...
A new study shows AI can detect Parkinson’s disease with 94.4% accuracy by analyzing volatile organic compounds in earwax samples.
Prothena announced partner Roche will advance prasinezumab into Phase III development in early-stage Parkinson’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results